Catalyst Wire Dossier Catalyst Wire Dossier

OP-1

osteogenic protein-1 · Stryker Biotech
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OP-1, covering 2010-06-17 to 2010-06-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1, Double-Blind, Randomized, Single Dose Escalation Safety Study of Intra-articular OP-1 in Subjects With Osteoarthritis of the Knee [Phase 1]

See pricing